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日本語演題名: 冠動脈攣縮治療戦略とカリウムチャネル開口薬 
Therapeutic targets of coronary artery spasm and K+ channel openers 
 
The primary hyperreactivity of vascular smooth muscle cells (VSMCs) has been shown 
to be involved in the pathogenesis of the coronary artery spasm (CAS) that refers to a 
sudden, intense vasoconstriction of an epicardial coronary artery that causes vessel 
occlusion or near occlusion. Thus, it is important to examine the reactivity of VSMCs to 
various stimuli in the light of intracellular signal transduction. While the motor 
proteins responsible for generation of force reside in the cell interior, most of the 
upstream signals generated upon GPCR stimulation, including ROK and PKC, are 
regulated at the plasma membrane. The hyperpolarization induced by K+ channel 
openers (KCO) has been shown remarkable influences on VSMC tonus. KCOs induce 
hyperpolarization to result in deactivation of VOCCs, inhibit the production of IP3 by 
the activation of GPCR, and reduce the Ca2+ sensitivity of contractile proteins, probably 
inhibiting ROK signaling. Although VOCC blockers are effective to control CAS, KCOs, 
like nicorandil, will be first choice for the treatment, since KCOs have a broader 
spectrum of relaxation mechanisms.  
J Pharmacol Sci 2013;121 Suppl 1:85P  
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【Conclusion】 
Ca sensitivity in vasc. sm. m. is increased or 
decreased by depolarization or 
hyperpolarization, respectively. 
The concept of hyperpolarization-relaxation 
coupling is very important, since we have 
intensively known the molecular mechanisms 
of KCO, EDHF and vasospasm. 
